Log in
Registration
Українська
English
Search for:
Home
Electronic publication
Fresh number
Archives
Authors
About Edition
Subscription
Requirements for authors
Reviewing
Editorial board
Organization of anticancer fight
Tumors of the chest cavity
Tumors of abdominal organs
Tumors of skin, soft tissues, bones
Breast tumor
Oncogynecology
Tumors of the head and neck
Oncurology
Oncohematology
Radiation diagnostics, radiation therapy
Experimental studies
Magazine online
All news
Keyword : targeted therapy
From theory to practice. The art of lung cancer treatment
Т. 14, №3 (55)
Zirabev as a representative of the largest family of biosimilars in oncology
Т. 14, №3 (55)
Sorafenib in the treatment of iodine-negative differentiated thyroid cancer
Authors: Solodiannykova O.I. Kmetyuk Y.V. Stolyarova O.Yu. Danylenko V.V.... Т. 14, №2 (54)
Induction targeted therapy with tyrosine kinase inhibitors in the treatment of EGFR-positive non-small cell lung cancer. Clinical case and discussion of features of therapeutic «targeted» tumor pathomorphosis
Authors: Sukhoversha O.A. Tsyhankov K.V. Kuzhevskyi I.V. Koval S.S. Т. 13, № 2 (50)
Treatment of patients with Hodgkin’s lymphoma after progression: chemosensitivity, transplantation and targeted drugs
Authors: Rudiuk T. Novosad O. Kryachok I. Т. 12, № 1-2 (45-46)
The role of targeted therapy in the treatment of patients with EGFR+ mutations of lung cancer (review)
Authors: Kolesnik O.P. Shevchenco A.I. Kadzhoian A.V. Kuzmenko V.A.... Т. 8, № 3 (31) 2018
Modern approaches to neoadjuvant therapy in patients with esophageal cancer
Authors: Kirkilevskyi S.I. Frydel R.I. Krahmalyov P.S. Kondratskyi Y. №3(19) 2015
Treatment of patients with advanced cutaneous melanoma: current approaches and perspectives
Authors: Kukushkina M.M. Korovin S.I. Palivets A. Ostafiychuk V.V.... №4(16) 2014
Chemotherapy and targeted therapy combination in patients with platinum-resistant ovarian cancer: case report
Authors: Kuznetsova O.V. Tchebotariova Rybin,G.M. Marzynkivska,A.I. N.V. Rybin A.I. №3(15) 2014
A clinical study of the efficacy of paclitaxel and bevacizumab as first-line therapy for HER2-negative breast cancer
№1(9) 2013